Axcelis Technologies, Inc.

05/04/2022

Axcelis announces Q1 results. Axcelis delivered exceptional financial performance well above guidance. Demand drives record bookings and backlog, Company expects to exceed revenue of $850M in 2022. on 5/5 @ 8:30a.m. ET www.axcelis.com

Axcelis Ion implantation systems, built on our next-gen Purion platform, delivers precision, purity, and productivity with the lowest cost of ownership.

04/26/2022

Axcelis will release financial results for the first quarter 2022 on Wednesday, May 4, 2022 at 4:00 p.m. Eastern Time (ET). The Company will host a call to discuss the results for the first quarter of 2022 on Thursday, May 5, 2022 at 8:30 a.m. ET. The call will be available to interested listeners via an audio webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com.

Axcelis Ion implantation systems, built on our next-gen Purion platform, delivers precision, purity, and productivity with the lowest cost of ownership.

10/15/2020

Axcelis will release financial results for the third quarter 2020 on Thursday, November 5, 2020 at 4:00 p.m. Eastern Time (ET). The Company will host a call to discuss the results for the third quarter 2020 on Friday, November 6, 2020 at 8:30 am ET. Access results and call at www.axcelis.com.

Axcelis Ion implantation systems, built on our next-gen Purion platform, delivers precision, purity, and productivity with the lowest cost of ownership.

05/05/2020

Axcelis announced financial results for Q1 2020. Company reports continued strong demand for Purion products. See detailed release at www.axcelis.com. Earnings call scheduled for tomorrow, 5/6 @ 8:30AM ET.

04/28/2020

Axcelis announced today that it has received orders for the Purion Dragon™ high current system from a leading memory manufacturer. The Purion Dragon™ is a revolutionary new high current implanter architecture, featuring innovative orthogonal beam optics, designed for advanced memory and logic applications. The orders include the successful completion of a tool evaluation with follow on business to the same memory customer. The systems will support high volume production of NAND memory devices. The follow on order shipped in Q1. Details at www.axcelis.com

04/14/2020

Axcelis beats guidance for Q1 2020. The Company announces strong financial performance and timing and availability of first quarter results and conference call. Full release at www.axcelis.com

04/02/2020

Axcelis announced that it has received an order to ship its first Purion system into Japan. The order, from a leading Japanese semiconductor manufacturer, is for the Purion XE Power Series™ implanter. This Purion XE product line extension will be used in high volume production of power devices supporting automotive, mobile and IoT applications. More details at www.axcelis.com.

02/05/2020

Axcelis announced financial results for Q4 and FY 2019. Company reports 94% increase in Q4 system revenues. A call to discuss results is scheduled for Thursday, February 6, at 8:30 am ET. Full press release and access call online @ www.axcelis.com

12/03/2019

Axcelis announced that its Board of Directors has increased its stock repurchase authorization to $50 million, expanding and extending the $35 million share repurchase authorization granted in December 2018. Ex*****on is planned through 2020. The purchases are funded from available working capital.

BEVERLY, Mass. , Dec. 3, 2019 /PRNewswire/ -- Axcelis Technologies , Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today announced that its Board of Directors has increased its stock repurchase authorization to $50 million ,